menu
    • menu

    Company profile for Valneva

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Valneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The Company has several vaccines in development, including unique vaccines against Lyme disease, COVID-19 and chikungunya. Valneva’s portfolio also includes two commercial vaccines for travelers.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ValnevaFrance Flag
    Country
    Country
    France
    Address
    Address
    6 rue Alain Bombard, 44800 Saint-Herblain
    Telephone
    Telephone
    +33 2 28 07 37 10
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://valneva.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/valneva/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/valnevase

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Valneva's Chikungunya Vaccine IXCHIQ Shows Strong Safety
    Valneva's Chikungunya Vaccine IXCHIQ Shows Strong Safety

    10 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/10/3203393/0/en/Valneva-Reports-Positive-Final-Phase-2-Antibody-Persistence-and-Safety-Results-in-Children-for-its-Chikungunya-Vaccine-IXCHIQ.html

    GLOBENEWSWIRE
    10 Dec 2025
    Share Share
    Valneva Reports Shares, Voting Rights as of Nov. 30, 2025
    Valneva Reports Shares, Voting Rights as of Nov. 30, 2025

    05 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/05/3200913/0/en/VALNEVA-Declaration-of-shares-and-voting-rights-November-30-2025.html

    GLOBENEWSWIRE
    05 Dec 2025
    Share Share
    Valneva Terminates 30 Amid Site Closure
    Valneva Terminates 30 Amid Site Closure

    01 Dec 2025

    // BIOSPACE

    https://www.biospace.com/biospace-layoff-tracker

    BIOSPACE
    01 Dec 2025
    Share Share
    Valneva To Further Consolidate Its Operations In France
    Valneva To Further Consolidate Its Operations In France

    26 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/26/3195261/0/en/Valneva-to-Further-Consolidate-its-Operations-in-France.html

    GLOBENEWSWIRE
    26 Nov 2025
    Share Share
    Valneva Reports Positive Phase 2 Results For Lyme Disease Vaccine
    Valneva Reports Positive Phase 2 Results For Lyme Disease Vaccine

    26 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/26/3194845/0/en/Valneva-Announces-Positive-Final-Phase-2-Results-for-Lyme-Disease-Vaccine-Candidate.html

    GLOBENEWSWIRE
    26 Nov 2025
    Share Share
    Valneva Reveals 9-Month 2025 Financials And Corporate Updates
    Valneva Reveals 9-Month 2025 Financials And Corporate Updates

    20 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/20/3191572/0/en/Valneva-Reports-Nine-Month-2025-Financial-Results-and-Provides-Corporate-Updates.html

    GLOBENEWSWIRE
    20 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search